| Epidemiology of Asthma in Children and Adults |
60 |
| The Burden of Pediatric Asthma |
49 |
| The Role of Inflammation in Venous Thromboembolism |
47 |
| Immunological Effects of Human Milk Oligosaccharides |
38 |
| The Epidemiology and Pathogenesis of Kawasaki Disease |
31 |
| Shaping the Gut Microbiota by Breastfeeding: The Gateway to Allergy Prevention? |
28 |
| Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives |
28 |
| Celiac Disease: A Review of Current Concepts in Pathogenesis, Prevention, and Novel Therapies |
27 |
| Diversity of Human Milk Oligosaccharides and Effects on Early Life Immune Development |
26 |
| Fortification of Human Milk for Preterm Infants: Update and Recommendations of the European Milk Bank Association (EMBA) Working Group on Human Milk Fortification |
25 |
| Managing Bardet-Biedl Syndrome-Now and in the Future |
21 |
| Culture-Negative Early-Onset Neonatal Sepsis - At the Crossroad Between Efficient Sepsis Care and Antimicrobial Stewardship |
20 |
| Recommendations for the Establishment and Operation of Human Milk Banks in Europe: A Consensus Statement From the European Milk Bank Association (EMBA) |
18 |
| Human Milk Oligosaccharides in the Prevention of Necrotizing Enterocolitis: A Journey From in vitro and in vivo Models to Mother-Infant Cohort Studies |
18 |
| Universal Newborn Screening for Severe Combined Immunodeficiency (SCID) |
17 |
| Pathophysiological Mechanisms of Asthma |
17 |
| Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases |
17 |
| Neonatal Hemodynamics: From Developmental Physiology to Comprehensive Monitoring |
16 |
| Compositional Dynamics of the Milk Fat Globule and Its Role in Infant Development |
16 |
| Difficult vs. Severe Asthma: Definition and Limits of Asthma Control in the Pediatric Population |
16 |
| The Prebiotic and Probiotic Properties of Human Milk: Implications for Infant Immune Development and Pediatric Asthma |
15 |
| Processing of Donor Human Milk: Update and Recommendations From the European Milk Bank Association (EMBA) |
15 |
| Human Milk: An Ideal Food for Nutrition of Preterm Newborn |
14 |
| Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning |
13 |
| Immune Response to Mycobacterium tuberculosis: A Narrative Review |
13 |
| Transplant-Associated Thrombotic Microangiopathy in Pediatric Hematopoietic Cell Transplant Recipients: A Practical Approach to Diagnosis and Management |
13 |
| Metabolic Bone Disease of Prematurity: Diagnosis and Management |
13 |
| Zebrafish as a Model for Drug Screening in Genetic Kidney Diseases |
13 |
| Immunomodulation to Prevent or Treat Neonatal Sepsis: Past, Present, and Future |
13 |
| Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge |
13 |
| Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress |
13 |
| Group B Streptococcal Maternal Colonization and Neonatal Disease: Molecular Mechanisms and Preventative Approaches |
12 |
| Aetiological Significance of Infectious Stimuli in Kawasaki Disease |
12 |
| Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development |
12 |
| Predictors of Mortality in Neonates and Infants Hospitalized With Sepsis or Serious Infections in Developing Countries: A Systematic Review |
12 |
| Genetics of Autosomal Recessive Polycystic Kidney Disease and its Differential Diagnoses |
12 |
| Asthma in Children and Adults-What Are the Differences and What Can They Tell us About Asthma? |
12 |
| Autologous Stem-Cell-Based Gene Therapy for Inherited Disorders: State of the Art and Perspectives |
12 |
| Human Milk Oligosaccharide Composition Is Associated With Excessive Weight Gain During Exclusive Breastfeeding-An Explorative Study |
12 |
| Malnutrition in Chronic Kidney Disease |
12 |
| Evolving Therapy for Celiac Disease |
12 |
| Sex Differences in Nutrition, Growth, and Metabolism in Preterm Infants |
11 |
| The Gut Microbiota-Host Partnership as a Potential Driver of Kawasaki Syndrome |
11 |
| Immunomodulation in Pediatric Asthma |
11 |
| Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome |
11 |
| Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2 |
11 |
| Childhood IgA Vasculitis (Henoch Schonlein Purpura) - Advances and Knowledge Gaps |
11 |
| Genomic Predictors of Asthma Phenotypes and Treatment Response |
11 |
| Invasive Meningococcal Disease in the Vaccine Era |
11 |
| Neonatal Encephalopathy: Need for Recognition of Multiple Etiologies for Optimal Management |
11 |
